Caitong International Asset Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.79K Buy
786
+652
+487% +$3.94K ﹤0.01% 1321
2026
Q1
$825 Sell
134
-4,115
-97% -$34.2K ﹤0.01% 1495
2025
Q4
$44.3K Buy
4,249
+3,554
+511% +$35.7K 0.01% 746
2025
Q3
$6.25K Sell
695
-72
-9% -$632 ﹤0.01% 1163
2025
Q2
$9.97K Buy
767
+603
+368% +$9.07K 0.01% 729
2025
Q1
$4.14K Buy
164
+89
+119% +$2.65K ﹤0.01% 1076
2024
Q4
$2.58K Buy
+75
New +$3.38K ﹤0.01% 1138

Other funds holding RXST

Caitong International Asset Management's RXST Position: Q2 2026 in Review

Caitong International Asset Management increased its RxSight (RXST) stake by 487% in Q2 2026, buying an estimated $3.94K and bringing the position to 786 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Caitong International Asset Management first reported a position in RXST in Q4 2024 and has held it in 7 quarters since. The position peaked at $44.3K in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Caitong International Asset Management held 786 shares of RxSight worth $3.79K as of Q2 2026.
  • Caitong International Asset Management bought 652 RxSight shares in Q2 2026, an estimated $3.94K.
  • RxSight made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1321 holding.
  • Caitong International Asset Management first reported a position in RxSight in Q4 2024 and has held it in 7 quarters since.
  • Caitong International Asset Management's RxSight position peaked at $44.3K in Q4 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.